In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Eposin, Vepesid, VP-16, Toposar, Etoposide Drug Master File in Korea (Eposin, Vepesid, VP-16, Toposar, Etoposide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Eposin, Vepesid, VP-16, Toposar, Etoposide. The MFDS reviews the Eposin, Vepesid, VP-16, Toposar, Etoposide KDMF as part of the drug registration process and uses the information provided in the Eposin, Vepesid, VP-16, Toposar, Etoposide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Eposin, Vepesid, VP-16, Toposar, Etoposide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Eposin, Vepesid, VP-16, Toposar, Etoposide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Eposin, Vepesid, VP-16, Toposar, Etoposide suppliers with KDMF on PharmaCompass.